scispace - formally typeset
I

Istvan Botos

Researcher at National Institutes of Health

Publications -  38
Citations -  3411

Istvan Botos is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Protein structure & Bacterial outer membrane. The author has an hindex of 23, co-authored 37 publications receiving 3032 citations.

Papers
More filters
Journal ArticleDOI

Structural basis of toll-like receptor 3 signaling with double-stranded RNA.

TL;DR: To establish the molecular basis for ligand binding and signaling, the crystal structure of a complex between two mouse TLR3-ECDs and dsRNA is determined at 3.4 angstrom resolution.
Journal ArticleDOI

The structural biology of Toll-like receptors.

TL;DR: The membrane-bound Toll-like receptors trigger innate immune responses after recognition of a wide variety of pathogen-derived compounds and the nature of the interactions of the TLR extracellular domains with their ligands varies markedly between TLR paralogs.
Journal ArticleDOI

The molecular structure of the Toll-like receptor 3 ligand-binding domain

TL;DR: The TLR3-ECD structure indicates how LRR loops can establish distinct pathogen recognition receptors, including insertions in the LRRs and 11 N-linked glycans.
Journal ArticleDOI

The catalytic domain of Escherichia coli Lon protease has a unique fold and a Ser-Lys dyad in the active site.

TL;DR: Alignment of the P domain catalytic pocket with those of several Ser-Lys dyad peptide hydrolases provides a model of substrate binding, suggesting that polypeptides are oriented in the Lon active site to allow nucleophilic attack by the serine hydroxyl on the si-face of the peptide bond.
Journal ArticleDOI

Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides.

TL;DR: The crystal structures of recombinant CV-N complexed to Man-9 and a synthetic hexamannoside show unequivocally the binding geometry of high mannose sugars toCV-N, permitting a better understanding of carbohydrate binding to this potential new lead for the design of drugs against AIDS.